Mondaq Australia: Intellectual Property
Corrs Chambers Westgarth
This decision provides some useful guidance for an area of trade mark law left largely untouched by Australian cases
Norton Rose Fulbright Australia
Difficulties faced in applying to register colour trade marks and useful lessons for future applicants of colour trade marks.
Shelston IP
Whether the failure of this Bill influences the future of the Innovation patent system in Australia remains to be seen.
Davies Collison Cave
In April 2018, the Australian Patent Office held the hearing of BGC Partners Inc [2018] APO 27, in which it refused a patent application in the area of financial trading for failing to claim patentable subject matter.
Shelston IP
It may be mere coincidence that second-tier patents regimes were considered simultaneously in Australia and New Zealand,.
Shelston IP
These proposed changes will impact on how Australia capitalises on its innovation strategy and competitive position.
Shelston IP
This article discusses some useful tips on how to read and understand prior art patent literature more efficiently.
Shelston IP
This article outlines main stages of the innovation process, relevant IP tools and intellectual asset advisory services.
Madgwicks
The ability to use dormant brands and trademarks must be considered when negotiating the purchase price of an agreement,.
Shelston IP
The parallels between NZ's proposed Advancement patent and Australia's current Innovation patent are readily apparent.
Shelston IP
Investors financing eligible Early Stage Innovation Companies may be entitled to tax concessions and CGT exemptions.
Jones Day
Rituximab is sold by Roche under the brand name "MabThera". Sandoz registered its rituximab biosimilar, "Riximyo", on the Australian Register of Therapeutic Goods in November 2017 for the same indications as MabThera, including the patented indications.
Stacks Law Firm
The new owner held the copyright to the building plans and objected to the construction of a house identical to his.
Pointon Partners
A colour can function as a trade mark if the public has come to identify the colour with a business' goods or services.
Shelston IP
Illustrates types of IP considerations made regarding research intended to lead to the development of a commercial product.
Norton Rose Fulbright Australia
The article explores the impact of 'fame tax' on individuals who use a separate entity to cash in on their image rights.
Madderns Patent & Trade Mark Attorneys
Bluescope Steel has engaged in a long running battle with IP Australia to protect branding on a pre-painted steel strip.
Madderns Patent & Trade Mark Attorneys
This recent decision is a cautionary tale about the effectiveness of generic confidentiality clauses in email footers.
Shelston IP
A strategic, planned, and holistic approach to the use of IP tools in the innovation process is critical for success.
Coleman Greig Lawyers
The registration of trade marks allows legal protection action against the use of the same or deceptively similar marks.
Most Popular Recent Articles
Coleman Greig Lawyers
This brand dispute is highlighting the importance of properly drafted Intellectual Property Licence Agreements.
Norton Rose Fulbright Australia
A branding strategy is a long term plan for the development of successful product marketing through brand awareness.
Norton Rose Fulbright Australia
A wide variety of grants and funding programs can assist start-ups and businesses develop and commercialise their IP.
Shelston IP
An Austrade approved QIP ('Quality Incentive Program') consultant would assist you with your EMDG application.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Swaab Attorneys
Parallel importation may not be an infringement of the trade mark rights of an overseas manufacturer in Australia.
Norton Rose Fulbright Australia
Individual athlete brands are valuable, exploitable and are assets which young ambitious athletes aspire to achieve.
Coleman Greig Lawyers
Employers should conduct an exit interview, with a signed declaration that the employee has returned all company property.
Shelston IP
It may be mere coincidence that second-tier patents regimes were considered simultaneously in Australia and New Zealand,.
Corrs Chambers Westgarth
This judgment does provide some clarity on the issue of anti-competitive purpose, for pharmaceutical patent owners.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter